Literature DB >> 32431815

Incidental synchronous bronchial tumour: an unusual bronchoscopic finding.

Umberto Caterino1, Dario Amore2, Chiara Petagna3, Albina Palma4, Danila Caroppo5, Simona Massa5.   

Abstract

We describe a patient with incidental endobronchial synchronous hamartoma and typical carcinoid with different management strategy.
© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  Carcinoid tumour; endobronchial treatment; hamartoma; lung lobectomy

Year:  2020        PMID: 32431815      PMCID: PMC7231806          DOI: 10.1002/rcr2.585

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


Clinical Image

A 49‐year‐old woman was admitted to our hospital due to paroxysmal dry cough and mild dyspnoea. She was treated with inhaled steroid and bronchodilator for asthma. On contrast‐enhanced chest computed tomography (CT) scan, a solid endobronchial lesion totally occluding the right upper bronchus and an incidental triangular‐shaped lesion on intermedius bronchus were shown (Fig. 1). Fibrobronchoscopy demonstrated a round‐shaped vascularized lesion with typical carcinoid findings located at the orifice of the right upper lobe bronchus and a soft polypoid lesion originating from the medial wall of the bronchus intermedius (Fig. 2A, B). Histological examinations revealed typical carcinoid and hamartoma. A different management strategy was performed [1]. Rigid bronchoscopy treatment with yttrium aluminium garnet (YAG) laser and right upper lobectomy allowed complete removal of the hamartoma and typical carcinoid [1, 2](Fig. 3).
Figure 1

Contrast‐enhanced chest computed tomography (CT) showed a vascularized round lesion with sub‐occlusion of the upper right bronchus (A) and a triangular lesion on intermedius bronchus (B).

Figure 2

Bronchoscopy view revealed a round‐shaped vascularized lesion sub‐obstructing the right upper lobe bronchus (A) and soft polypoid lesion originating from the distal bronchus intermedius (B). Bronchial scarring post laser‐assisted mechanical resection (C) and closure of bronchial stump following upper right lobectomy (D).

Figure 3

Moderately cellular cartilage fragments without atypia. (A) The polygonal tumour cells arranged in organoid and trabecular growth pattern (haematoxylin–eosin (H–E) stain, 2 mm). (B) Abundant eosinophilic cytoplasm with round‐oval nuclei and inconspicuous nucleoli were observed (H–E stain, 10×).

Contrast‐enhanced chest computed tomography (CT) showed a vascularized round lesion with sub‐occlusion of the upper right bronchus (A) and a triangular lesion on intermedius bronchus (B). Bronchoscopy view revealed a round‐shaped vascularized lesion sub‐obstructing the right upper lobe bronchus (A) and soft polypoid lesion originating from the distal bronchus intermedius (B). Bronchial scarring post laser‐assisted mechanical resection (C) and closure of bronchial stump following upper right lobectomy (D). Moderately cellular cartilage fragments without atypia. (A) The polygonal tumour cells arranged in organoid and trabecular growth pattern (haematoxylineosin (H–E) stain, 2 mm). (B) Abundant eosinophilic cytoplasm with round‐oval nuclei and inconspicuous nucleoli were observed (H–E stain, 10×).

Disclosure Statement

Appropriate written informed consent was obtained for publication of this case report and accompanying images.
  2 in total

1.  Rare airway tumors: an update on current diagnostic and management strategies.

Authors:  Marwan Saoud; Monali Patil; Samjot Singh Dhillon; Saraswati Pokharel; Anthony Picone; Mark Hennon; Sai Yendamuri; Kassem Harris
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

2.  Endobronchial Hamartoma Subtotally Occluding the Right Main Bronchus and Mimicking Bronchial Carcinoid Tumor.

Authors:  Filippo Lococo; Carla Galeone; Luciano Lasagni; Cristiano Carbonelli; Elena Tagliavini; Roberto Piro; Luigi Zucchi; Giorgio Sgarbi
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.